Health Care & Life Sciences » Pharmaceuticals | Komipharm International Co. Ltd.

Komipharm International Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
82
2,150
6,548
227
5,196
Depreciation, Depletion & Amortization
1,051
1,962
2,634
3,334
3,511
Other Funds
49
11
42
-
-
Funds from Operations
1,415
1,850
4,961
3,822
5,076
Changes in Working Capital
2,519
4,385
2,041
2,613
4,841
Net Operating Cash Flow
3,934
2,535
2,920
1,209
236
Capital Expenditures
28,708
11,198
12,274
12,238
6,465
Sale of Fixed Assets & Businesses
11
8
2
675
5,012
Purchase/Sale of Investments
6,758
94
4,916
4,196
702
Net Investing Cash Flow
35,475
12,285
6,031
6,611
811
Issuance/Reduction of Debt, Net
25,556
9,499
4,260
3,405
683
Net Financing Cash Flow
25,606
19,687
15,221
18,959
317
Net Change in Cash
5,934
4,874
6,342
13,973
743
Free Cash Flow
20,998
10,539
10,397
7,885
2,444
Deferred Taxes & Investment Tax Credit
1,482
1,535
2,821
507
1,031
Other Sources
144
42
1,556
761
1,605
Change in Capital Stock
-
10,200
19,523
22,364
1,000
Exchange Rate Effect
1
8
72
417
622
Other Uses
163
1,044
230
6
43

About Komipharm International Co.

View Profile
Address
17 Gyeongje-ro
Siheung GY 15094
Korea, Republic Of
Employees -
Website http://www.komipharm.com
Updated 09/14/2018
Komipharm International Co., Ltd. engages in the development and manufacturing of natural food additives, veterinary vaccines and pharmaceuticals. It operates through Animal Health and Pharmaceuticals divisions. The Animal Health division manufactures veterinary products such as vaccines, antibiotics, antibacterial, nutrition, metabolic, immune boosters, digestive enzymes, expectorant, hormone, skin disease, anesthetic, antipyretic-analgesics and organic acid for being used to livestock, aqua and pet animals.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.